U.S. Stem Cell, Inc.
USRMDelisted- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001388319
U.S. Stem Cell, Inc. was delisted in 2026; its insiders filed their last Form 4 on Apr 29, 2022; 1 institution reported holding it in 13F filings for Q2 2026, worth $11 in total; no superinvestor held it.
Q2 2026 vs. Q1 2026
How the institutions holding U.S. Stem Cell, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 111.1K | +111.1K |
| Value | $0 | $11 | +$11 |
New holders (1)
Institutions that held U.S. Stem Cell, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wealthspire Advisors, LLC | 111,111 | $11 | 0.00% |
Sold out (0)
Institutions that held U.S. Stem Cell, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
None.